This research investigates early mechanisms of abnormal brain aging and validates early biomarkers to identify pre-symptomatic stages before clinical symptoms appear.
This research uses a multi-modal approach to reveal the neural mechanisms underlying psychotic spectrum disorders and to provide objective biomarkers for assessing disease progression and treatment efficacy.